Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$56.4M |
| 2 |
Chemed
CHE
|
+$53.8M |
| 3 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$53.1M |
| 4 |
Petrobras
PBR
|
+$52.7M |
| 5 |
FIEG
FI Enhanced Global High Yield Exchange Traded Notes
FIEG
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMER
FIRSTMERIT CORP
FMER
|
+$58.7M |
| 2 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$38.2M |
| 3 |
PL
PROTECTIVE LIFE CORP
PL
|
+$37.8M |
| 4 |
Sally Beauty Holdings
SBH
|
+$36.2M |
| 5 |
TSMC
TSM
|
+$35.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.26% |
| 2 | Healthcare | 14.53% |
| 3 | Technology | 12.41% |
| 4 | Industrials | 7.4% |
| 5 | Consumer Discretionary | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Invesco S&P 500 Top 50 ETF
XLG
$10.5B
| $17.4M | 0.04% |
1,261,050
+38,190
| +3% | +$525K |
|
202
Cullen/Frost Bankers
CFR
$10.3B
| $17.2M | 0.04% |
224,807
+393
| +0.2% | +$30.8K |
|
203
Zimmer Biomet
ZBH
$18.4B
| $17.1M | 0.04% |
175,223
+60
| +0% | +$5.9K |
|
204
Mastercard
MA
$510B
| $16.4M | 0.03% |
221,494
-270
| -0.1% | -$20.6K |
|
|
CYN
205
DELISTED
CITY NATIONAL CORPORATION
CYN
| $16.4M | 0.03% |
216,208
+12,961
| +6% | +$980K |
|
|
NTUS
206
DELISTED
Natus Medical Inc
NTUS
| $16.2M | 0.03% |
+548,495
| New | +$15.1M |
|
207
Kroger
KR
$35.4B
| $16.1M | 0.03% |
619,280
-50,830
| -8% | -$1.28M |
|
|
GHL
208
DELISTED
Greenhill & Co., Inc.
GHL
| $15.8M | 0.03% |
339,380
+13,185
| +4% | +$620K |
|
209
Equifax
EFX
$20.7B
| $15.6M | 0.03% |
208,980
-23,255
| -10% | -$1.77M |
|
|
STJ
210
DELISTED
St Jude Medical
STJ
| $15.4M | 0.03% |
255,663
-4,751
| -2% | -$310K |
|
211
CONMED
CNMD
$1.41B
| $15.2M | 0.03% |
413,810
+346,510
| +515% | +$13.7M |
|
|
HOT
212
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $15.1M | 0.03% |
181,391
-2,226
| -1% | -$184K |
|
|
PCH
213
DELISTED
PotlatchDeltic
PCH
| $15M | 0.03% |
374,101
-9,200
| -2% | -$384K |
|
214
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
| $15M | 0.03% |
234,798
+8,386
| +4% | +$525K |
|
215
Hancock Whitney
HWC
$6.14B
| $14.1M | 0.03% |
438,922
+35,707
| +9% | +$1.19M |
|
216
Fidelity National Information Services
FIS
$23.8B
| $13.7M | 0.03% |
243,592
-26,162
| -10% | -$1.48M |
|
|
BEAV
217
DELISTED
B/E Aerospace Inc
BEAV
| $13.6M | 0.03% |
223,095
-6,344
| -3% | -$401K |
|
218
Rockwell Automation
ROK
$52.4B
| $13.5M | 0.03% |
123,284
-7,260
| -6% | -$853K |
|
219
Omnicell
OMCL
$1.69B
| $13.5M | 0.03% |
492,478
+82,478
| +20% | +$2.26M |
|
220
Cencora
COR
$60.7B
| $13.1M | 0.03% |
169,692
-13,965
| -8% | -$1.06M |
|
221
KLA
KLAC
$236B
| $12.5M | 0.03% |
1,590,750
-177,040
| -10% | -$1.34M |
|
222
T. Rowe Price
TROW
$25.6B
| $12.5M | 0.03% |
159,839
-16,827
| -10% | -$1.35M |
|
223
Toll Brothers
TOL
$14B
| $12.4M | 0.03% |
399,427
+24,050
| +6% | +$824K |
|
224
Terex
TEX
$7.11B
| $12.4M | 0.03% |
389,641
+3,892
| +1% | +$142K |
|
225
BorgWarner
BWA
$13.2B
| $12M | 0.03% |
258,496
-5,790
| -2% | -$317K |
|
Similar funds
Ken Fisher's Q3 2014 Portfolio in Review
As of Q3 2014, Ken Fisher held 645 positions worth $46.9B, down 1.4% from $47.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q3 2014 filing shows 47 new, 202 increased, 264 reduced and 61 closed positions. Its largest new stake was Chemed: 530,910 shares worth $54.6M. The largest sale was FIRSTMERIT CORP, an estimated $58.7M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- Ken Fisher's largest Q3 2014 buy was Chemed: 530,910 shares worth $54.6M.
- Ken Fisher added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2014, an estimated $56.4M increase.
- Ken Fisher's biggest Q3 2014 reduction was FIRSTMERIT CORP, cutting an estimated $58.7M.
- Ken Fisher fully exited PROTECTIVE LIFE CORP in Q3 2014, selling an estimated $37.8M.
- Ken Fisher's ten largest holdings make up 22% of its $46.9B portfolio in Q3 2014.
- Ken Fisher opened 47 new positions and closed 61 in Q3 2014.
- Ken Fisher's portfolio value fell 1.4% quarter-over-quarter to $46.9B.
Based on Fisher Asset Management's 13F filing for Q3 2014, filed 20 Oct 2014.